Compass Therapeutics Announces Appointment of Two New
BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Gray Strategic. Real-time updates on events, politics, business and more.